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The Human Tissue–Biomaterial Interface:
A Role for PPARg-Dependent Glucocorticoid
Receptor Activation in Regulating the CD163 +
M2 Macrophage Phenotype
Samuel J. Bullers, PhD,1,* Simon C. Baker, PhD,1 Eileen Ingham, PhD,2 and Jennifer Southgate, PhD 1
In vivo studies of implanted acellular biological scaffolds in experimental animals have shown constructive
remodeling mediated by anti-inflammatory macrophages. Little is known about the human macrophage re-
sponse to such biomaterials, or the nature of the signaling mechanisms that govern the macrophage phenotype
in this environment. The cellular events at the interface of a tissue and implanted decellularized biomaterial
were examined by establishing a novel ex vivo tissue culture model in which surgically excised human urinary
tract tissue was combined with porcine acellular bladder matrix (PABM). Evaluation of the tissue–biomaterial
interface showed a time-dependent infiltration of the biomaterial by CD68+ CD80 - macrophages. The mi-
gration of CD68+ cells from the tissue to the interface was accompanied by maturation to a CD163hi phenotype,
suggesting that factor(s) associated with the biomaterial or the wound edge was/were responsible for the active
recruitment and polarization of local macrophages. Glucocorticoid receptor (GR) and peroxisome proliferator
activated receptor gamma (PPARg) signaling was investigated as candidate pathways for integrating inflam-
matory responses; both showed intense nuclear labeling in interface macrophages. GR and PPARg activation
polarized peripheral blood-derived macrophages from a default M1 (CD80+ ) toward an M2 (CD163+ ) phe-
notype, but PPARg signaling predominated, as its antagonism blocked any GR-mediated effect. Seeding on
PABM was effective at polarizing peripheral blood-derived macrophages from a default CD80+ phenotype on
glass to a CD80- phenotype, with intense nuclear localization of PPARg. These results endorse in vivo ob-
servations that the infiltration of decellularized biological scaffolds, exemplified here by PABM, is pioneered by
macrophages. Thus, it appears that natural factors present in PABM are involved in the active recruitment and
polarization of macrophages to a CD163+ phenotype, with activation of PPARg identified as the candidate
pathway. The harnessing of these natural matrix-associated factors may be useful in enhancing the integration
of synthetic and other natural biomaterials by polarizing macrophage activation toward an M2 regulatory
phenotype.
Introduction
The attributes of tissue-derived acellular biologicalscaffolds have been reviewed extensively over the last
decade.1 However, there remains a lack of understanding of
the molecular and cellular mechanisms that facilitate the
integration of biological scaffolds following implantation. It
is axiomatic that surgical implantation of any biomaterial
will initiate an innate immunological response: the intensity,
duration, and outcome of which will be dependent upon the
nature of the biomaterial. The innate response to biomate-
rials is coordinated by macrophages. Widely recognized for
their role in the innate immune response to microorganisms,
macrophages have also been identified as the key cells in-
filtrating sites of tissue injury and have been shown to play
an orchestrating role in wound healing processes.2 These
cells promote healing by responding to tissue damage,
stimulating angiogenesis and inducing collagen synthesis.3
The functional plasticity of the macrophage response to a
diverse range of protective, pathological, and tissue re-
modeling processes has resulted in the recognition of dif-
ferent activation states.4–6 As first proposed, macrophages
were considered to polarize between a ‘‘classically activat-
ed’’ pro-inflammatory phenotype and an ‘‘alternatively
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activated’’ anti-inflammatory phenotype,7 later referred to as
M1 and M2, respectively.5 Studies in which tissue-derived
acellular biological scaffolds have been implanted in vivo
have observed that macrophages displaying an anti-inflam-
matory or ‘‘M2’’ phenotype are associated with remodeling
and integration, while pro-inflammatory or ‘‘M1’’ macro-
phages are associated with encapsulation.8–10 Transcrip-
tional profiling of this M1/M2 dichotomy has identified a
range of molecules that can be employed to characterize
macrophage polarization.11
It is now recognized that by integrating responses to
different environmental cues, macrophages display a plas-
ticity of phenotypes across a spectrum of activation states
encompassing host defense, wound healing, tissue pathology,
and immune regulation, which are dynamic and overlapping.6
There is a paucity of research aimed at understanding the
signaling mechanisms that direct the macrophage pheno-
type in the context of the biological scaffold. Defining the
factors that govern the response of the macrophage to the
unique environment of the implanted acellular biological
scaffold may help direct the future development of functional
natural and synthetic biomaterial scaffolds. Current models
for the assessment of macrophage responses to biomaterials
are limited either to in vivo implantation in rodents, or simple
cell culture systems, often using immortalized ‘‘macrophage’’
cell lines that may not exhibit the plasticity of their primary
mononuclear phagocyte counterparts. Coupled with this is a
need to develop relevant preclinical models that are able to
investigate and predict biomaterial performance. Although a
few individual studies have incorporated biomaterials into
human organ culture systems,12–14 these reports have not
considered the response of tissue-derived immunological
cells to the biomaterials.
The aim of the present study was to develop an ex vivo
biomaterial–human tissue interface at which to examine the
early cell integration events and from this identify potential
signaling mechanisms that govern the human macrophage
phenotype, as informed by in vitro studies of peripheral-
blood-monocyte-derived macrophages.
Materials and Methods
Harvest and preparation of porcine acellular
bladder matrix
Porcine bladders were obtained from the local abattoir
and transported in transport medium15 consisting of HBSS
(with Ca2 + and Mg2 + ) containing 10mM HEPES (pH 7.6),
20KIU$mL-1 Trasylol (Bayer Healthcare Pharmaceu-
ticals), 20U$mL-1 penicillin, and 20mg$mL- 1 streptomycin.
Preparation of porcine acellular bladder matrix (PABM) was
performed by decellularizing the bladder by distension and
immersion in a series of buffers containing EDTA, SDS, and
DNAse/RNase, and with terminal disinfection in 0.1% (v/v)
peracetic acid (pH 7.2) for 3 h at 37C, followed by repeated
washing in phosphate-buffered saline (PBS), as previously
detailed.16 All solutions were sterilized prior to use and pro-
cessing was performed in a class II biological safety cabinet
following standard aseptic technique. Complete decellular-
ization of the PABM was examined by staining with Hoechst
33258 (H33258) to confirm absence of nuclear material.16
For gamma irradiation, PABM was cut aseptically into
*1-cm2 pieces before being sandwiched within surgical
mesh and packaged into a foil pouch. The pouch was then
inserted into a Tyvek pouch and heat-sealed. The packaged
biomaterial was transferred to Isotron Limited (Swindon)
for gamma irradiation at 30 kGy.
Organ culture
An organ culture system17 was adapted whereby a slit was
introduced into a 1-cm2 piece of PABM biomaterial to ac-
commodate a 0.5-cm2 piece of fresh urinary tract tissue. To
establish the system, split-thickness fresh porcine bladder tis-
sue (consisting of lamina propria and epithelium) was derived
by incising horizontally between the lamina propria and
the detrusor smooth muscle of the urinary bladder. Follow-
ing optimization, a human tissue–biomaterial organ culture
model was developed using surgically resected pieces of full-
thickness human urinary tract tissue; this tissue was obtained
as surplus tissue from surgery and had informed patient consent
and research ethics committee approval for use in research.
The tissue–biomaterial constructs were cultured on the
membrane of a cell culture well insert with 3-mm pores (cat-
alogue number 734-0034; BD Falcon) within a six-well plate
(Corning Costar; Fig. 1A). Constructs were maintained at an
air–liquid interface in Waymouth’s medium (Life Technolo-
gies) supplemented with 10% (v/v) fetal bovine serum (FBS;
Sera Laboratories International), 300mg$mL-1 L-ascorbic acid
(Sigma-Aldrich), 2mg$mL-1 hydrocortisone hemisuccinate
(Sigma-Aldrich), and 450ng$mL-1 ferrous sulfate (Fisons), as
described for maintaining organ cultures.17 Omission of hy-
drocortisone hemisuccinate or ferrous sulfate from the medium
was carried out in control experiments to preclude their in-
fluence on the results. Medium was exchanged every 48h.
Isolation and culture of human peripheral blood
mononuclear cells
Peripheral blood was obtained with informed consent from
healthy volunteers at the York Clinical Research Facility
based at York Teaching Hospital. Blood was collected into
lithium heparin Monovette tubes (Sarstedt) and peripheral
blood mononuclear cells (PBMCs) were isolated over Lym-
phoprep (Axis-Shields) before phagocytic mononuclear cells
were identified and enumerated using latex bead ingestion.
Monocytes were isolated by selective adherence to glass and
cultured in RPMI1640 supplemented with 10% (v/v) heat-
inactivated FBS and 2mM L-glutamine in the presence of an
agonist, antagonist, or vehicle control. The agonists used
were as follows: 250 nM dexamethasone (1126; Tocris),
100 nM phorbol 12-myristate 13-acetate (PMA; Sigma), and
1mM troglitazone (T2573; Sigma-Aldrich). The peroxisome
proliferator activated receptor gamma (PPARg) antagonist was
5mM T0070907 (2301; Tocris). Appropriate vehicle controls
were included in all experiments. Monocytes were seeded on
the PABM within a seeding ring and isolated by selective
adherence before culturing the constructs in RPMI1640
supplemented with 10% (v/v) heat-inactivated FBS and
2mM L-glutamine.
Culture of THP-1 cells
The human acute monocytic leukemia–derived THP-1
cell line (ATCC number TIB-202) was cultured in
suspension in RPMI1640 supplemented with 10% (v/v)
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FIG. 1. (A) Schematic cross-section of the biomaterial–organ culture system. Urinary tract tissue was inserted within the
porcine bladder biological scaffold and cultured for up to 11 days. (B) Photograph of the apical aspect of the biomaterial–
organ culture construct within the culture well insert. Porcine split-thickness tissue appears yellow in color and is sur-
rounded by the white PABM. For scale, the base of the well insert has an effective growth area of 4.2 cm2. (C) Grayscale
image of a whole-section slide scan of a biological scaffold–porcine bladder tissue section. The tissue can be seen within the
central region of the section and is flanked either side by porcine bladder biological scaffold. Arrows indicate bladder
epithelial cells covering the surface of the PABM. Scale bar represents 700 mm. (D) Hematoxylin-and-eosin-stained sections
of the allogeneic porcine biomaterial–organ culture model. Histological staining of sections of the allogeneic biological
scaffold–organ culture constructs at days 2, 6, and 11 showed a gradual increase of cells within the biological scaffold. Inset
image on day 11 highlights that cells present in the PABM have a mononuclear phagocyte-like morphology (arrows). Scale
bars represent 100mm. (E) Alkaline phosphatase immunolabeling for porcine CD107a expression in tissue sections from the
allogeneic biomaterial–organ culture system. Images were captured at the PABM–tissue interface and within the central
regions of the tissue. Cells that were present in the biological scaffold were intensely labeled for porcine CD107a (arrows).
Dotted lines represent biomaterial–tissue interface. Scale bars represent 100 mm. PABM, porcine acellular bladder matrix.
Color images available online at www.liebertpub.com/tea
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heat-inactivated FBS, 2mM L-glutamine, and 0.05mM b-
mercaptoethanol (Sigma-Aldrich). THP-1 cells were dif-
ferentiated to adherent macrophage-like cells by culture in
100 nM PMA for 48 h.
Primary antibodies
The phenotype of mononuclear phagocytes was assessed
using mouse monoclonal antibodies against CD11b (Clone
238446, MAB16991; R&D Systems), CD11b-APC (Clone
238446, FAB16991A; R&D Systems), CD68 (Clone PG-
M1, M0876; Dako), CD80 (Clone 37711, MAB140; R&D
Systems), CD107a (Clone 4E9/11, MCA2315; Serotec),
CD163 (Clone EDhu-1, MCA1853; Serotec), CD163-FITC
(Clone EDhu-1, MCA1853F; Serotec), glucocorticoid re-
ceptor (GR, Clone 4H2, NCL-GCR; Novacastra), and
PPARg (Clone E-8, SC-7273; Santa Cruz). Antibody con-
centrations were determined by titration.
Histology and immunohistochemistry
Organ culture constructs and PABM were fixed in either
zinc salts or 10% (v/v) neutral-buffered formalin and pro-
cessed into paraffin wax. Tissue sections (5mm) were cut onto
Superfrost microscope slides and stained with hematoxylin
and eosin. For immunolabeling, endogenous peroxidase was
blocked with 3% (v/v) H2O2, before heat retrieval of antigens
by boiling for 10min in 10mM citric acid buffer (pH 6.0), or
1mM EDTA buffer (pH 8.0), or enzymatic retrieval by in-
cubating in 0.1% (w/v) porcine trypsin in 0.1% (w/v) CaCl2
at 37C for 1min followed by heat retrieval in 10mM citric
acid buffer (pH 6.0). Endogenous avidin and biotin were
blocked (Vector Laboratories), followed by blocking of Fc
receptors with 10% (v/v) rabbit serum (Dako). Primary an-
tibodies were applied overnight at 4C. After washing, rabbit
anti-mouse IgG biotinylated secondary antibody (E0354;
Dako) was applied to each slide for 30min at ambient tem-
perature. Secondary antibody was detected using the Vector
Stain ABC streptavidin-horseradish peroxidase amplification
kit (Vector Laboratories), followed by incubation with dia-
minobenzidine substrate (Sigma-Aldrich), or the Vector Stain
streptavidin-alkaline phosphatase amplification kit followed
by incubation with alkaline phosphatase substrate (Vector
Laboratories). Immunolabeled tissue sections were counter-
stained in Mayer’s hematoxylin and mounted in DPX. Im-
munoperoxidase labeling of antigens expressed at low levels
was performed using the catalyzed signal amplification kit
(Dako), according to manufacturer’s instructions. Irrelevant
primary antibody controls and positive control tissues were
included in all experiments. Images were either captured on
an Olympus BX60 microscope using Image Pro Plus software
(version 4.5.1.29; Media Cybernetics) or whole tissue sec-
tions were captured on a slide scanner (MetaSystems). Where
antigen expression was quantified, analysis regions were set
using Image J Software (National Institute of Health).
Immunoblotting
Cells were lysed with 50mL of 2% (w/v) SDS lysis buffer
containing 13mM dithiothreitol (Sigma-Aldrich) and pro-
tease inhibitor cocktail (Sigma-Aldrich). Protein (20mg)
from each sample was separated on reduced 3–8% (w/v)
Tris-acetate NuPAGE gels (Life Technologies) and elec-
trotransferred onto a PVDF membrane (Millipore). The
membrane was blocked in 50% (v/v) Odyssey blocking
buffer (Li-Cor Biosciences) in 10mM Tris-buffered saline
(pH 7.4; TBS) for 1 h and probed sequentially with primary
antibody overnight at 4C and then Alexa Fluor 680 con-
jugated goat anti-mouse IgG secondary antibody (A21057;
Molecular Probes), with washing between, before imaging
on an Odyssey Infrared scanner (Li-Cor Biosciences).
Flow cytometry
Adherent monocyte-derived macrophages were harvested
from the culture substrate by incubation in 1% (w/v) EDTA
for 10min and scraping into ice-cold PBS. PBMCs and
adherent monocyte-derived macrophages in suspension
were adjusted to 1 · 106 cells$mL - 1 in ice-cold PBS and
incubated with LIVE/DEAD Fixable Dead Cell Stain
(Molecular Probes) for 30min at ambient temperature in
order to identify and exclude dead cells from the analysis.
The cell suspensions were labeled with 11mL of fluorescent-
conjugated primary antibody or isotype control for 30min
on ice before washing and fixing in 1% (v/v) neutral-buffered
formalin overnight. Immunolabeled-fixed cells were analyzed
on a three-laser CyAn flow cytometer (Dako) and the flow
cytometry data were interpreted using the Summit software
package (version 4.3; Dako).
Immunofluorescence microscopy
Goat serum (10% v/v) was applied to methanol–acetone-
fixed cultures for 1 h before addition of primary antibody and
incubation at 4C overnight in a humidified environment.
Alexa Fluor 594-conjugated goat anti-IgG secondary anti-
body (A11005; Molecular Probes) was added for 1 h at am-
bient temperature, before washing, nuclear counterstaining
with 0.1mg$mL- 1 bis-benzimide (33258; Hoechst), and
mounting in 0.1% (w/v) p-phenylendiaminodihydrochloride
(Sigma-Aldrich) in 90% (w/v) glycerol in PBS (pH 8). Im-
munolabeling was assessed by epifluorescence on an Olympus
BX60 microscope. Gray-scale images (32-bit) were merged to
produce a color composite image using Image J software.
Statistical analysis
All statistical analyses were performed using InStat sta-
tistical software version 3.05 (GraphPad). Mann–Whitney U
tests were performed to test significance ( p< 0.05) between
data sets with a small or unequal number of replicates.
Results
Examination of the allogeneic ex vivo biomaterial–
organ culture model
Incorporation of the PABM into replicate organ cultures
provided a system for investigating the biomaterial–tissue
interface over multiple days. Porcine split-thickness urinary
tract tissue was initially used as the live component in order
to establish the model. The apical aspect of the constructs
showed a ‘‘fried egg’’-like appearance within the culture
well insert (Fig. 1B). Visualization of the histological sec-
tion through the whole construct showed that the live uri-
nary tract tissue component was flanked on either side by the
PABM to produce two ex vivo biomaterial–tissue interfaces
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(Fig. 1C). Histological analysis of constructs harvested from
culture at days 2, 6, and 11 revealed that the biomaterial–
tissue interface was maintained throughout the culture pe-
riod (Fig. 1D). There was an increase in the number of cells
within the PABM over time, from which it was inferred that
cells had migrated from the live tissue into the PABM. The
infiltrating cells had a large cytoplasmic volume and a
kidney-shaped nucleus, indicative of mononuclear phago-
cytes (Fig. 1D). Immunolabeling of the tissue sections for
the porcine macrophage-associated marker CD107a showed
a time-associated increase in the number of intense
CD107a + cells at the biomaterial–tissue interface and in-
filtrating the PABM (Fig. 1E). CD107ahi cells with an
equivalent morphology were not observed within the central
regions of the live urinary tract tissue component of the
constructs, although smaller CD107alo cells were apparent
in the central regions at early time points, suggesting cell
migration and maturation over time (Fig. 1E). Use of
gamma-irradiated PABM in the biomaterial–organ culture
model showed inhibited migration of CD107ahi cells into
the matrix, with CD107ahi cells lining up along the tissue–
biomaterial interface (Supplementary Fig. S1; Supplemen-
tary Data are available online at www.liebertpub.com/tea).
Histological analysis of biomaterial–human
tissue interface
Culture of surgically-resected human urinary tract tissue
in the biomaterial–organ culture model produced an ex vivo
xenogeneic biomaterial–human tissue interface. Replicate
constructs were harvested at days 2, 6, and 11 for histo-
logical analysis. Immunolabeling of histological sections of
the biomaterial–human organ culture constructs showed
CD68 + cells at the biomaterial–tissue interface and within
the PABM at day 11, indicating interaction and infiltration
by human mononuclear phagocytes (Fig. 2A). Investigation
FIG. 2. (A) Analysis of human macrophage-associated marker expression at the biomaterial–human tissue interface.
Biomaterial–organ culture constructs created using human ureteric tissue were harvested at day 11 and processed for
immunohistochemistry. Images show the PABM on the left and the tissue on the right of each image. Boxes indicated the
areas of the higher magnification images. All scale bars represent 100mm. (B) Quantification of CD163 immunolabeling
throughout the xenogeneic biomaterial–organ culture constructs. Three sections separated by > 100 mm throughout the
biomaterial–organ culture constructs harvested at days 2, 6, and 11 were immunolabeled for CD163 expression. The symbol
* represents a significant difference ( p < 0.05) between median values as determined by the nonparametric Mann–Whitney
U test. (C) Infiltration of the PABM by CD163 + cells was reproducible in multiple donors. Evaluation of the biomaterial–
human tissue interface showed that CD163 + cells migrated from the tissue into the PABM. Boxes indicated the areas of the
higher magnification images. Dotted lines represent biomaterial–tissue interface. All scale bars represent 100mm. Color
images available online at www.liebertpub.com/tea
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of the expression of macrophage functional markers showed
an absence of the proinflammatory macrophage marker
CD80, both at the biomaterial–human tissue interface (Fig.
2A) and within the central region of the live human tissue,
although the antibody was shown to be immunoreactive on
control human colon tissue (data not shown). Conversely,
immunolabeling of the biomaterial–human organ culture
constructs with an antibody to the anti-inflammatory mac-
rophage marker CD163 showed striking expression of the
antigen at the PABM–human tissue interface at day 11 of
culture (Fig. 2A). Quantification of CD163 expression in
multiple histological sections taken at different levels
through the tissue constructs showed that the number of
CD163 + cells at the biomaterial–tissue interface increased
between days 2 and 11, which reached significance at days 6
and 11 (Fig. 2B). The presence of CD163 + cells at the
biomaterial–tissue interface and infiltration of macrophages
into the PABM by day 11 was demonstrated in constructs
developed using tissue from all three independent donors
(Fig. 2A, C).
CD163 expression by human macrophages
To gain understanding of CD163 regulation in human
macrophages, peripheral blood monocytes and monocyte-
derived macrophages were labeled for CD163. Human
peripheral blood monocytes were identified by CD11b ex-
pression, of which*80% (n= 6) expressed CD163 (Fig. 3A,
B); this was in agreement with recent analysis.18 Immuno-
fluorescence imaging of mature human monocyte-derived
macrophages cultured on glass for 11 days showed that all
mononuclear phagocytes maintained expression of CD11b as
they matured from monocytes to macrophages. However,
expression of CD163 was restricted to a subpopulation of
monocyte-derived macrophages (Fig. 3C). Flow cytometric
analysis of CD163 expression by CD11b+ monocyte-derived
FIG. 3. (A) Flow cytometric analysis of CD163 expression by CD11b + peripheral blood monocytes (left flow cytometry
dot plot) and day 11 monocyte-derived CD11b+ macrophages (right flow cytometry dot plot). Regions (R3, R4, R5, R6,
R11, R12, R13, R14) of analysis were determined based on isotype control labeling. (B) Change in expression of CD163
protein upon differentiation of CD11b + peripheral blood monocytes (n = 6 donors) to CD11b + monocyte-derived macro-
phages (n = 3 donors). Regions of analysis were assigned based on isotype control labeling. The symbol * represents a
significant difference ( p< 0.05) in the percentage of CD163 + cells between peripheral blood monocytes and monocyte-
derived macrophages as determined by the nonparametric Mann–Whitney U test. (C) Representative immunofluorescent
imaging of human peripheral blood monocyte–derived macrophages immunolabeled with anti-CD11b or anti-CD163. Scale
bar represents 100mm. Color images available online at www.liebertpub.com/tea
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macrophages cultured on a glass substrate for 11 days showed
a gradient of CD163 expression, with some 18% (n= 3) of
CD11b+ monocyte-derived macrophages defined as CD163hi
(Fig. 3B). This indicated that in the absence of exogenous
stimulation, CD163 was expressed constitutively by a sub-
population of peripheral-blood-derived macrophages.
Nuclear receptor modulation of CD163 expression
on macrophages
CD163 expression has been reported to be regulated by
anti-inflammatory glucocorticoids.19 We used the synthetic
glucocorticoid dexamethasone to activate the GR in the
monocyte/macrophage THP-1 cell line and in human-
peripheral-blood-derived monocyte–derived macrophages
(Fig. 4). Monocytic THP-1 cells did not express CD163, but
differentiation to adherent macrophage-like cells with PMA
resulted in de novo expression of the CD163 antigen, which
was further enhanced by stimulation with dexamethasone (Fig.
4A). Similarly, culture of human-monocyte-derived macro-
phages with dexamethasone for 6 days resulted in CD163
expression by all cells (Fig. 4B). The nuclear receptor PPARg
has been implicated in mediating an anti-inflammatory phe-
notype in macrophages and has also been shown to play a role
in orchestrating wound healing processes following tissue in-
jury20 (reviewed in Michalik and Wahli21). The hypothesis
that PPARg activation would modulate expression of CD163
by monocyte-derived macrophages was therefore tested.
Activation of PPARg with troglitazone resulted in a
qualitative increase in the number of CD163+ macro-
phages at 11 days (Fig. 5A). This was confirmed by flow
cytometry, which showed that activation of PPARg in-
creased the CD163hi population from 18% to 36% at day
11 (Fig. 5B). By contrast, inhibition of PPARg activation
with T0070907 resulted in a total loss of expression of
CD163 by all monocyte-derived macrophages (Fig. 5A). A
population of CD11b + monocyte-derived macrophages
that did not express CD163 in response to the PPARg
agonist was observed by immunofluorescence and flow
cytometry, indicating that not all macrophages responded
to the activation of PPARg in the same way (Fig. 5B). The
PPARg antagonist T0070907 inhibited the glucocorticoid-
mediated upregulation of CD163 by monocyte-derived
macrophages, indicating an interdependency of the two
signaling pathways (Fig. 5C).
To confirm the role of PPARg in inducing an anti-
inflammatory macrophage phenotype, the effects of
PPARg on the proinflammatory macrophage marker CD80
were also investigated. All monocyte-derived macrophages
showed a basal level of CD80 expression when cultured on
glass for 11 days in control culture conditions (Fig. 6).
Antagonism of PPARg with T0070907 resulted in a major
increase in the intensity of CD80 immunolabeling by
peripheral-blood-monocyte-derived macrophages, while
activation of PPARg totally ablated CD80 expression
(Fig. 6).
FIG. 4. (A) De novo expression
of CD163 by THP-1 cells when
differentiated into adherent macro-
phage-like cells by PMA and fur-
ther enhancement in response to
the GR agonist dexamethasone
(250 nM) treatment for 48 h.
b-Actin was used as a loading
control. (B) Human peripheral
blood monocyte–derived macro-
phages at day 6 in either the
presence of 250 nM dexamethasone
or the DMSO vehicle control. Scale
bar represents 100mm. GR, gluco-
corticoid receptor; PMA, phorbol
12-myristate 13-acetate. Color
images available online at
www.liebertpub.com/tea
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Nuclear receptor expression and localization
in the xenogeneic biomaterial–organ culture model
Immunohistochemical evaluation of the PABM–human
tissue organ culture constructs demonstrated intense nuclear
localization of both PPARg and GR in the cells present at the
biomaterial–tissue interface and in cells that had infiltrated
the PABM, indicating potential activation. PPARg+ cells
present within the bladder matrix material exhibited kidney-
shaped nuclei indicative of mononuclear phagocytes (Fig. 7).
CD80 expression and PPARc localization in
macrophages cultured on different substrates
Macrophages seeded onto glass showed a basal level of
CD80 expression as indicated earlier; however, when the
FIG. 5. (A) The regulation of CD163 expression by PPARg. As observed previously, a subpopulation of monocyte-
derived macrophages expressed CD163 in the presence of the DMSO vehicle control. Inhibition of PPARg by culture of
monocyte-derived macrophages in the presence of 5mM T0070907 for 11 days showed an absence of CD163 + subpopu-
lation. Activation of PPARg by culture of the monocyte-derived macrophages in the presence of the PPARg agonist
troglitazone at 1mM for 48 h, followed by culture in the DMSO vehicle control medium for 9 days, showed an increase in
the CD163 + subpopulation. Scale bar represents 100mm. (B) Flow cytometric analysis of monocyte-derived macrophages
activated with troglitazone for 48 h followed by culture in control medium for a further 9 days. Cells were harvested and
immunolabeled with anti-CD163-FITC and anti-CD11b-APC. Regions (R3, R4, R5, R6) of analysis were assigned based on
isotype control labeling. Percentage of CD163 + CD11b + monocyte-derived macrophages is shown. (C) Monocyte-derived
macrophages were cultured in the presence of 250 nM dexamethasone or 250 nM dexamethasone and 5mM T0070907.
Inhibition of PPARg by T0070907 completely ablated dexamethasone-induced CD163 expression. Scale bar represents
100mm. PPARg, peroxisome proliferator activated receptor gamma. Color images available online at www.liebertpub.com/tea
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macrophages were seeded directly onto the PABM, they
showed an absence of CD80 expression and intense nuclear
localization of PPARg (Fig. 8). Conversely, macrophages
cultured on a glass substrate showed a combination of cy-
toplasmic and nuclear PPARg localization (Fig. 8).
Discussion
We have developed a novel ex vivo culture model to
enable examination of the cellular events that occur at the
interface between a tissue and implanted decellularized
biomaterial. The biomaterial–organ culture system facili-
tates the study of biomaterial–tissue interfaces in an organ-
specific context using allogeneic or xenogeneic biomaterial
combinations. By examining the interface between urinary
tract tissue and PABM, we have demonstrated that infil-
tration of the biomaterial was mediated by a pioneering
population of cells identified as macrophages on the basis
of kidney-shaped nuclear morphology and expression of
CD107a + (in porcine) and CD68 + (in human) tissue sys-
tems. Gamma irradiation of the PABM inhibited the mi-
gration of CD107a + cells from the tissue into the matrix,
suggesting that the native matrix structure facilitated
FIG. 6. The PPARg-dependent
regulation of the macrophage
costimulatory receptor CD80. Hu-
man peripheral blood monocyte–
derived macrophages expressed a
basal level of CD80 when in the
presence of the DMSO vehicle
control for 11 days. Inhibition of
PPARg by culture of monocyte-
derived macrophages in the pres-
ence of 5mM T0070907 for 11 days
on a glass substrate showed a
qualitative increase in CD80 ex-
pression. Activation of PPARg by
culture of the monocyte-derived
macrophages in the presence of the
PPARg agonist troglitazone at
1 mM for 48 h, followed by culture
in the DMSO vehicle control me-
dium for 9 days, showed a loss in
CD80 expression by monocyte-
derived macrophages. Scale bar
represents 100 mm. Color images
available online at www
.liebertpub.com/tea
FIG. 7. The GR and PPARg show intense nuclear locali-
zation at the biomaterial–tissue interface but not within the
central regions of the tissue. Day-11 biomaterial–organ culture
constructs were immunolabeled for GR and PPARg expres-
sion in the central regions of the tissue compared with the
biomaterial–tissue interface. PPARg+ cells within the bio-
logical scaffold showed a large cytoplasm-to-nuclei ratio and a
kidney-shaped nuclei indicative of mononuclear phagocytes
(arrow and inset image). Scale bar represents 100mm. Color
images available online at www.liebertpub.com/tea
FIG. 8. Expression of CD80 and localization of PPARg in
monocyte-derived macrophages seeded onto either a glass
substrate or the PABM. Arrows denote macrophages on
PABM showing nuclear PPARg localization. Scale bar rep-
resents 100mm. Color images available online at www.lie-
bertpub.com/tea
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macrophage infiltration. In the human system, the phenotype
of the infiltrating macrophages was further defined as CD163hi
in conjunction with intense nuclear expression of PPARg
and GR.
Most commonly, biomaterials are tested by subcutaneous
implantation in rodents and it has been proposed that the
resultant macrophage phenotype may be used to predict the
outcome of biomaterial implantation in man.9 However, it is
well known in the toxicity field that the extrapolation from
rodents to humans can be inaccurate.22 Porcine models are
suggested to be superior to rodent systems for studies of
immunological mechanisms, due in part to similarities be-
tween porcine and human macrophages in terms of nitric
oxide induction in response to lipopolysaccharide and the
regulation of arginine metabolism.23 In addition, pigs are
useful as preclinical models for experimental surgery (e.g.,
for reconstructive urology24) due to their similar size and
organ arrangement to humans. A disadvantage of porcine
systems, however, is a dearth of well-characterized macro-
phage-associated markers for porcine cells and thus the
potential to develop human ex vivo models is of immediate
advantage and relevance.
It is well established that damage caused by a wounding
event will recruit leukocytes to the site of injury.2 The identi-
fication of CD68+ cells with distinct kidney-shaped nuclei at
the tissue–PABM interface revealed that macrophages were the
first cells to interact with the decellularized bladder matrix.
Further characterization of the interface CD68+ macrophages
showed that these cells were negative for the proinflammatory
marker CD80, whereas CD163 was expressed. CD163 has
been identified as a macrophage marker associated with bio-
material integration; for example, CD80- CD163+ M2 mac-
rophages have been demonstrated at the site of constructive
tissue remodeling following implantation of a porcine-derived
biological scaffold into Sprague–Dawley rats in vivo.25 Inter-
estingly, in our own studies of synthetic polycaprolactone
scaffolds implanted in a rat model, the CD68+ macrophages
that colonized and coated the biomaterial were CD163 negative
despite a noninflammatory remodeling immune response.26 In
the context of the interface between a tissue wound and de-
cellularized natural matrix, the undetermined question was
whether the expression of CD163 by macrophages reflected a
passive, default phenotype (e.g., in the absence of proin-
flammatory stimuli), or was the result of a more active process.
From the immunohistochemical analysis it was possible
to infer that CD68 + cells migrated to the interface region
over time and accompanying this, there was maturation to a
CD163hi phenotype. This suggested that factor(s) associated
with either the biomaterial or the wound edge may be re-
sponsible for the local recruitment and maturation of mac-
rophages. GR and PPARg are members of the nuclear
receptor superfamily and both are candidates for mediating
anti-inflammatory responses by acting as ligand-activated
transcription factors for specific gene expression programs.
Emerging evidence of cross-talk between PPARg and GR
has suggested that the nuclear receptors probably function in
combination to integrate local and systemic responses to
inflammation.27 By immunohistochemistry, intense nuclear
labeling of GR and PPARg by macrophages at the interface
initiated a more detailed examination of the potential role
of these pathways in PBMCs and derived mononuclear
phagocyte cell cultures. The results using PBMCs showed
that it was possible to derive cells of an equivalent pheno-
type to those seen at the biomaterial interface and, em-
ploying CD80 and CD163 as markers, we confirmed that
PBMC-derived macrophages could be polarized between
classical M1 (CD80 + ) and M2 (CD163 + ) phenotypes by
modulating the activation of these anti-inflammatory regu-
lators. These two markers represent well-characterized polar
responses on a spectrum of macrophage activation states and
have previously been used in combination to define an in-
tegrative response.25 The study presented here demonstrates
a novel regulatory mechanism behind the CD80/CD163
switch that could potentially be harnessed to polarize mac-
rophage phenotype toward an anti-inflammatory or regula-
tory response during biomaterial integration.
Despite the biomaterial–organ culture model providing
new insight into the human response to decellularized bio-
logical scaffolds, we recognize the limitation of extrapo-
lating the ex vivo approach to an in vivo implantation model
with regards to recruitment of inflammatory cells and fully
modeling an integrative response. One unresolved question
from the tissue culture model is whether the observed
CD68 + cells represented a tissue-resident macrophage
population or were derived from circulating monocytes
captured in the peripheral vasculature of the tissue at
the time of excision? Nevertheless, we revealed that the
majority of circulating CD11b + monocytes showed consti-
tutive expression of CD163. We further observed hetero-
geneity in the monocyte-derived macrophage population by
identifying a minority of PBMC-derived macrophages that
retained CD163 expression even after culture in nonindu-
cing conditions. We are unaware of any other study that
documents this in vitro CD163 + subpopulation, although
Philippidis et al. documented increased CD163 expression
by human-monocyte-derived macrophages in culture28 and
Eligini et al. recently described the spontaneous differenti-
ation of distinct macrophage phenotypes in vitro where
CD163 expression was greater in monocyte-derived mac-
rophages with a rounded, rather than spindle, morphology.29
Porta et al. described a population of macrophages that are
‘‘tolerant’’ in response to endotoxin and display an inherent
skewing toward the M2 phenotype with impaired M1 re-
sponses.30 It is intriguing to postulate that the CD163+
population maintained in culture represents monocyte-
derived macrophages with a greater propensity toward anti-
inflammatory/M2 macrophage function.
Here, stimulation of GR with dexamethasone induced
upregulation of CD163 by all cells in culture, whereas
PPARg activation enhanced only the size of the constitutive
CD163 + subpopulation. By contrast, antagonism of PPARg
ablated all CD163 expression and de-repressed CD80 ex-
pression. This latter is in agreement with other studies that
have shown PPARg activation of human-monocyte-derived
dendritic cells to repress the lipopolysaccharide-induced
expression of CD80.31,32 Finally, we established a depen-
dency for GR signaling on PPARg activity, as inhibition of
PPARg function inhibited the glucocorticoid-dependent
upregulation of CD163.
In regard to the context of the tissue–biomaterial inter-
face, the question is whether the activation of PPARg and
GR was effected through factors in the wound environment
or in the decellularized biomaterial? Here, the decellularized
biomaterial was found to be effective in polarizing the
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macrophage from a basal CD80 + phenotype (the default
phenotype on a glass substrate) to a CD80 - phenotype with
intense nuclear localization of PPARg (when seeded on
PABM). These results indicated that, as well as the factors
in the wound environment, there may be natural agonists
present in the PABM that provide an inherent advantage to
natural biomaterials, as supported by studies of T-cell po-
larization.33 Future work will examine this hypothesis and
further explore the consequence of crosslinking and terminal
sterilization on the effectiveness of PABM and other natural
biomaterials to act through PPARg and GR to mediate an
integrative CD80 - CD163+ macrophage response.
Conclusions
The observation of anti-inflammatory human macro-
phages with intense nuclear localization of nuclear receptors
at biomaterial–tissue interface provides new insight into the
factors determining the host response to biomaterials by
indicating a potential role for nuclear receptor signaling at a
biomaterial–human tissue interface. Natural factors incor-
porated into biomaterials may help polarize the macrophage
phenotype and be used to promote and enhance the efficacy
and integration of biomaterials into the host.
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